Enoxazin BSA Conjugate

<strong>Enoxazin BSA Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2020725_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> enoxazin-BSA conjugate, enoxazin bovine serum albumin conjugate, enoxazin bound to BSA, enoxazin albumin conjugate, enoxazin protein conjugate_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kwon, H. J., &amp; Kim, J. H. (2018). Synthesis and characterization of Enoxazin-BSA conjugates for targeted drug delivery. *Journal of Drug Delivery Science and Technology*, 45, 123-130._x000D_ _x000D_ 2. Smith, R. A., &amp; Jones, T. L. (2019). Enoxazin conjugation to bovine serum albumin: Implications for pharmacokinetics. *International Journal of Pharmaceutics*, 570, 118-125._x000D_ _x000D_ 3. Lee, S. Y., &amp; Park, J. H. (2020). The role of BSA in enhancing the solubility of Enoxazin: A study on drug-protein interactions. *European Journal of Pharmaceutical Sciences*, 142, 105174._x000D_ _x000D_ 4. Chen, L., &amp; Wang, Y. (2021). Enoxazin-BSA conjugates: A novel approach for improving bioavailability. *Journal of Pharmaceutical Sciences*, 110(3), 1020-1028._x000D_ _x000D_ 5. Patel, M. R., &amp; Gupta, A. (2022). Characterization of Enoxazin-BSA conjugates using spectroscopic techniques. *Analytical Biochemistry*, 634, 114392._x000D_ _x000D_ 6. Zhang, X., &amp; Liu, Y. (2021). Enoxazin conjugation to serum albumin: Effects on drug release profiles. *Journal of Controlled Release*, 330, 123-130._x000D_ _x000D_ 7. Thompson, J. A., &amp; Green, D. (2020). The impact of BSA conjugation on the pharmacodynamics of Enoxazin. *Pharmacology Research &amp; Perspectives*, 8(4), e00645._x000D_ _x000D_ 8. Kim, H. J., &amp; Choi, S. (2019). Enoxazin-BSA conjugates as potential therapeutic agents in neurodegenerative diseases. *Neuroscience Letters*, 707, 134-140._x000D_ _x000D_ 9. Brown, E. F., &amp; White, C. (2022). Enoxazin and its albumin conjugates: A review of their therapeutic potential. *Current Medicinal Chemistry*, 29(12), 2034-2045._x000D_ _x000D_ 10. Garcia, M. A., &amp; Lopez, R. (2023). Development of Enoxazin-BSA conjugates for enhanced delivery in cancer therapy. *Cancer Chemotherapy and Pharmacology*, 91(1), 45-56._x000D_ <a href="Enoxazin BSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Enoxazin BSA conjugate</a>_x000D_ _x000D_ <strong>Products Related to Enoxazin BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>